NLRP3 Inflammasome activation and cell death
#Osteoarthritis #ClinicalTrials #Research #KnowledgeTranslation #DrugDevelopment To view or add a comment, sign in The evidence for Arthramid 2.5% iPAAG is growing, and its redefining what long-term success looks like
doi: 10.1097/MOL.0000000000000750
Known type 2 diabetes mellitus agents such as metformin, thiazolidinediones (TZDs), sulfonylureas, or basal insulin may also be considered
Takaaki Kanemaru (Department of Morphology Core Unit, Kyushu University Hospital) and The Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences, which is partially supported by the Mitsuaki Shiraishi Fund for Basic Medical Research
Our experienced medical staff uses proper injection technique to minimize pain and bruising